Blog
RSS FeedPosted by Michael Wonder on 16 May 2023
RACGP welcomes asthma puffer decision saving Aussie families time and money
15 May 2023 - The Royal Australian College of GPs (RACGP) has welcomed the PBAC's decision to remove limitations requiring ...
Posted by Michael Wonder on 12 May 2023
PBAC backs ongoing access to low-dose asthma puffer for Aussie kids
12 May 2023 - The independent, expert group advising the Australian Government on PBS medications has reviewed its recommendation to put ...
Posted by Michael Wonder on 10 May 2023
Reforming opioid dependence treatment access
10 May 2023 - In the 2023-24 Budget, the Australian Government committed $377.3 million over 4 years from 2023–24 (and $98.4 ...
Posted by Michael Wonder on 30 Apr 2023
Schedule of Pharmaceutical Benefits - 1 May 2023
1 May 2023 - The May 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 24 Apr 2023
Changes to treatment phases and authority levels in medicines for the treatment of Alzheimer’s disease
24 April 2023 - From 1 May 2023, the PBS item codes for donepezil, galantamine, memantine and rivastigmine, for the treatment ...
Posted by Michael Wonder on 16 Apr 2023
Price of a life: Australians wait two years longer for breakthrough medicines than US citizens
16 April 2023 - Australians are waiting two years longer to access new lifesaving subsidised medicines because of pharma giants. Now, ...
Posted by Michael Wonder on 16 Apr 2023
Australian cancer patients spend $200 million a year on treatments not on the PBS and it’s got to change
16 April 2023 - Australian cancer patients were spending in excess of $200m each year of their own money on therapies ...
Posted by Michael Wonder on 11 Apr 2023
New life saving medicines
11 April 2023 - The Australian Government has added the two medicines, Kanuma (sebelipase alfa) and Cerdelga (eliglustat) to the Life ...
Posted by Michael Wonder on 10 Apr 2023
Cheaper medicines for graft versus host disease, chronic rhinosinusitis and oesophageal cancer
10 April 2023 - For the first time Jakavi (ruxolitinib) will be listed for the treatment of patients with either acute ...
Posted by Michael Wonder on 06 Apr 2023
Life changing cystic fibrosis treatment now available to children 6 years and above
6 April 2023 - From 1 May 2023, children aged 6 to 11 with cystic fibrosis will have access to ...
Posted by Michael Wonder on 03 Apr 2023
Nucala (mepolizumab) is now listed on the PBS for Australians with chronic rhinosinusitis with nasal polyps
3 April 2023 - Nucala is the first biologic treatment to be PBS-subsidised for the treatment of severe chronic rhinosinusitis with ...
Posted by Michael Wonder on 01 Apr 2023
Schedule of Pharmaceutical Benefits - 1 April 2023
1 April 2023 - The April 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Mar 2023
Expanded access to subsidised oral antiviral Paxlovid and other COVID-19 supports
30 March 2023 - From 1 April, more than 160,000 people aged 60 to 69 will have access to the ...
Posted by Michael Wonder on 17 Mar 2023
Government maintains access to fast acting insulin
17 March 2023 - The Albanese Government has secured access to Fiasp and Fiasp FlexTouch on the PBS for Australians ...
Posted by Michael Wonder on 05 Mar 2023
Catherine has stage four breast cancer, but she can't access a new treatment in Australia
3 March 2023 - In 2015, twelve weeks after the birth of her second daughter, Catherine King was diagnosed with late-stage ...